Pharma Journalist 9001 posts 0 comments

Excalipoint Therapeutics and DP Technology have announced a strategic collaboration to develop a new artificial intelligence (AI) platform designed to speed up the discovery of T-cell…
Read More...

Clinical-stage radiopharmaceutical company AdvanCell has raised US$315 million in an oversubscribed Series D financing round to accelerate the development of its targeted cancer…
Read More...

Merck, known as MSD outside the United States and Canada, has announced positive results from its Phase 3 KEYNOTE-C93 clinical trial evaluating KEYTRUDA (pembrolizumab) as a first-line…
Read More...

Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its supplemental Biologics License Application (sBLA) for Gazyva/Gazyvaro…
Read More...

Harbour BioMed and Kelun-Biotech have announced that China's National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for…
Read More...

Takeda has announced a long-term collaboration with the Indonesian government to strengthen the country's plasma collection and manufacturing capabilities, with the aim of improving…
Read More...

Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of SBT-77-7101, an investigational regulatory T cell (Treg) therapy being developed…
Read More...

Novartis has entered into a new collaboration with artificial intelligence company Chai Discovery to accelerate the discovery of therapeutic antibodies using advanced AI technology. The…
Read More...

AstraZeneca has signed an exclusive licensing agreement with China's Dizal Pharmaceutical Co., Ltd. to acquire the worldwide rights to develop and commercialize Zegfrovy…
Read More...

Roche has received CE Mark certification for its Elecsys IGRA TB test, a new blood-based diagnostic designed to identify tuberculosis infection, also known as latent tuberculosis, in…
Read More...